| Compositions and methods for treating anemia |
2023-8-03 |
2023-10-11 |
|
| 5-((halophenyl)-3-halo-pyridin-2-yl)-nitrile derivative as intermediate in … |
2023-5-18 |
2023-7-26 |
|
| Compositions and methods for treating anemia |
2023-4-25 |
2023-7-04 |
|
| Selective phd1 inhibitor compounds, compositions, and methods of use |
2022-12-16 |
2023-6-22 |
|
| Picolinamide compounds as selective phd1 inhibitors, compositions, and methods … |
2022-12-16 |
2023-6-22 |
|
| Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic … |
2022-10-26 |
2022-12-01 |
|
| Methods for treating viral infections, organ injury, and related conditions |
2022-10-26 |
2023-5-11 |
|
| phd inhibitor compounds, compositions and use |
2022-10-14 |
2022-10-21 |
|
| phd inhibitor compounds, compositions and use |
2022-10-12 |
2022-10-21 |
|
| Prolyl hydroxylase inhibitors and methods of use |
2022-7-27 |
2023-6-29 |
|
| Therapeutic methods using vadadustat |
2022-4-25 |
2022-6-01 |
|
| Modulation of drug-drug interactions of vadadustat |
2022-3-01 |
2023-1-16 |
|
| Therapeutic methods using vadadustat |
2022-1-10 |
2022-11-01 |
|
| Compounds and composition for the treatment of anemia |
2022-1-10 |
2022-10-01 |
|
| Phd inhibitor compounds, compositions, and methods of use |
2021-8-13 |
2023-6-21 |
|
| Manufacturing process for 3,5-dichloropicolinonitrile for synthesis of … |
2021-7-01 |
2022-1-06 |
|
| Modulation of drug-drug interactions of vadadustat |
2021-6-18 |
2022-4-16 |
|
| Treatment of viral infections, of organ injury, and of related conditions using … |
2021-4-20 |
2021-10-28 |
|
| PHD inhibitor compounds, compositions and uses thereof |
2021-3-19 |
2023-1-13 |
|
| Method for producing nitrogen-containing heteroarylcarboxamide acetic acid … |
2020-12-09 |
2023-5-25 |
|
| Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic … |
2020-11-12 |
2021-7-08 |
|
| Compositions and methods for treatment of inflammatory disorders |
2019-10-03 |
2020-8-01 |
|
| Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2- carbonyl] … |
2019-5-08 |
2021-1-15 |
|
| Compositions for use in methods of treatment of hemoglobin disorders |
2018-8-01 |
2019-2-07 |
|
| Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, … |
2018-5-25 |
2018-9-21 |
|
| Prolyl hydroxylase inhibitors |
2018-2-20 |
2020-2-18 |
2020-2-18 |
| Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic … |
2017-7-11 |
2019-1-30 |
|
| Compound and composition for stabilizing hypoxia inducible factor-2 alpha as … |
2016-10-06 |
2017-3-30 |
|
| With the method for the activators for treating intraocular pressure of TIE-2 |
2016-9-22 |
2018-7-17 |
|
| Compositions and methods for treating ocular diseases |
2016-7-14 |
2016-8-31 |
|
| COMPOSITIONS AND METHODS FOR THE TREATMENT OF THE ANEMIA |
2016-3-31 |
2017-6-28 |
|
| Deuterium-enriched hypoxia-inducible factor prolyl hydroxylase enzyme … |
2016-3-18 |
2018-1-24 |
|
| SOLID FORMS OF ACID 2- (5- (3-FLUOROPHENIL) -3-HYDROXYPYCLINAMIDE) ACETIC, ITS … |
2016-1-22 |
2017-5-17 |
|
| COMPOSITIONS AND METHODS TO TREAT ANEMIA |
2015-12-11 |
2016-5-17 |
|
| Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and … |
2015-6-10 |
2019-1-31 |
|
| Hptp-beta inhibitors |
2015-3-13 |
2017-2-22 |
|
| The method preparing N benzyl 3 hydroxyl 4 substituted pyridine 2 (1H) ketone |
2015-2-18 |
2016-12-14 |
|
| Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic … |
2014-11-14 |
2022-6-28 |
|
| Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic … |
2014-11-14 |
2022-6-28 |
|
| Methods for treating vascular leak syndrome |
2014-6-04 |
2014-10-09 |
|
| For treating the composition, preparation and method of eye disease |
2014-3-14 |
2019-4-16 |
2019-4-16 |
| Compounds, compositions, and methods for preventing metastasis of cancer cells |
2014-3-11 |
2014-7-31 |
|
| Treatment of Ocular Disease |
2012-10-15 |
2013-4-18 |
|
| Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, … |
2012-6-05 |
2015-11-03 |
|
| For preparing [(3-pyridone-2-carbonyl) amino] alkanoic acid, ester and the … |
2012-6-05 |
2016-11-30 |
2016-11-30 |
| Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as … |
2012-6-05 |
2016-11-01 |
|
| Human protein tyrosine phosphatase inhibitors and method of use |
2011-12-01 |
2012-3-29 |
|
| Human protein tyrosine phosphatase inhibitors and methods of use |
2011-12-01 |
2012-3-29 |
|
| Compositions and methods for treating ocular edema, neovascularization and … |
2011-10-05 |
2012-6-28 |
|
| Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase |
2011-9-12 |
2013-8-20 |
2013-8-20 |
| N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones |
2010-7-28 |
2012-3-13 |
2012-3-13 |
| 用于制备[(3-羟基吡啶-2-羰基)氨基]链烷酸、酯和酰胺的方法 |
2012-6-05 |
2016-11-30 |
2016-11-30 |